SubHero Banner

Invanz® (ertapenem) – First-time generic

June 26, 2018 - Aurobindo announced the FDA approval of an AP-rated generic version of Merck’s Invanz (ertapenem) injection, for the treatment of adult patients and pediatric patients (3 months of age and older) with certain moderate to severe infections caused by susceptible isolates of designated microorganisms; and for the prevention of surgical site infection following elective colorectal surgery.

Download PDF